Literature DB >> 9498809

Continuous monitoring of ATP levels in living insulin secreting cells expressing cytosolic firefly luciferase.

P Maechler1, H Wang, C B Wollheim.   

Abstract

The second messenger role of ATP in insulin secretion was investigated in living INS-1 insulinoma cells. ATP-dependent luminescence was monitored in cells expressing high levels of firefly luciferase under the control of the tetracycline-dependent transactivator. The calibration of luminescence in permeabilized cells yielded similar ATP levels as those obtained in cell extracts with a conventional ATP assay. Stimulation of insulin secretion by glucose or methyl-succinate was correlated with rises of cellular ATP in simultaneous measurements. ATP generation was decreased by inhibition of the ADP-ATP translocase. This approach demonstrates the feasibility of defining the dynamic relationship between ATP and other parameters involved in metabolism-secretion coupling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498809     DOI: 10.1016/s0014-5793(97)01618-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets.

Authors:  S Carobbio; H Ishihara; S Fernandez-Pascual; C Bartley; R Martin-Del-Rio; P Maechler
Journal:  Diabetologia       Date:  2003-12-20       Impact factor: 10.122

2.  Metabolic activation-driven mitochondrial hyperpolarization predicts insulin secretion in human pancreatic beta-cells.

Authors:  Akos A Gerencser
Journal:  Biochim Biophys Acta Bioenerg       Date:  2018-06-08       Impact factor: 3.991

3.  Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction.

Authors:  Ning Li; Thierry Brun; Miriam Cnop; Daniel A Cunha; Decio L Eizirik; Pierre Maechler
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

4.  Mitochondrial glutamate carrier GC1 as a newly identified player in the control of glucose-stimulated insulin secretion.

Authors:  Marina Casimir; Francesco M Lasorsa; Blanca Rubi; Dorothée Caille; Ferdinando Palmieri; Paolo Meda; Pierre Maechler
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

5.  Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function.

Authors:  P B M de Andrade; B Rubi; F Frigerio; J M W van den Ouweland; J A Maassen; P Maechler
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

6.  Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.

Authors:  A E Karlsen; S G Rønn; K Lindberg; J Johannesen; E D Galsgaard; F Pociot; J H Nielsen; T Mandrup-Poulsen; J Nerup; N Billestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

7.  D-glucose metabolism in normal dispersed islet cells and tumoral INS-1 cells.

Authors:  A B Nadi; E Olivares; W J Malaisse
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

8.  Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism.

Authors:  Laurène Vetterli; Thierry Brun; Laurianne Giovannoni; Domenico Bosco; Pierre Maechler
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

9.  New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters.

Authors:  Carl D Gajewski; Lichuan Yang; Eric A Schon; Giovanni Manfredi
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

10.  Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.

Authors:  Tyler B Tarr; David Lacomis; Stephen W Reddel; Mary Liang; Guillermo Valdomir; Michael Frasso; Peter Wipf; Stephen D Meriney
Journal:  J Physiol       Date:  2014-07-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.